Related Experiment Video

Updated: May 3, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

1.8K

Regulation of renal fibrosis by Smad3 Thr388 phosphorylation

Xinli Qu1, Xueling Li2, Yaowu Zheng3

  • 1Department of Anatomy and Developmental Biology, Monash University, Clayton, Australia.

The American Journal of Pathology
|February 4, 2014
PubMed

Insights

Phosphorylation of Smad3 at T388 in the MH2 domain is crucial for transforming growth factor-β (TGF-β)-induced fibrosis. This novel site regulates Smad3 binding and extracellular matrix production in fibrotic kidney disease.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Nephrology

Background:

  • Transforming growth factor-β (TGF-β) signaling is a key driver of tissue fibrosis.
  • Smad3 protein is a major mediator of TGF-β's profibrotic effects.
  • Smad3 activity is regulated by phosphorylation at various sites.

Purpose of the Study:

  • To investigate the role of a novel Smad3 phosphorylation site, T388 within the MH2 domain, in regulating TGF-β signaling and fibrosis.
  • To determine the functional consequences of T388 phosphorylation on Smad3 activity and downstream targets.

Main Methods:

  • Confocal microscopy with a phospho-specific antibody to detect Smad3 T388 phosphorylation.
  • In vitro studies using TGF-β1 stimulation and Smad3 T388/V mutant constructs.
  • Analysis of Smad3 binding to Smad4 and CDK8.
  • Assessment of collagen I gene promoter activity and extracellular matrix production.

Main Results:

  • Smad3 T388 phosphorylation was detected in myofibroblasts and tubular epithelial cells in human and mouse fibrotic kidney disease models, but not in normal kidneys.
  • TGF-β1 induced Smad3 T388 phosphorylation in a biphasic pattern in vitro.
  • T388 phosphorylation enhanced Smad3 binding to Smad4 and CDK8, but did not affect nuclear translocation.
  • Phosphorylation of T388 was essential for TGF-β-induced collagen I gene expression and extracellular matrix production.

Conclusions:

  • Phosphorylation of T388 in the Smad3 MH2 domain is a critical regulatory mechanism in the profibrotic TGF-β/Smad3 pathway.
  • This finding has direct implications for understanding and potentially treating fibrotic kidney diseases.
  • Targeting Smad3 T388 phosphorylation may offer a therapeutic strategy for fibrotic conditions.

More Related Videos

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

7.9K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K